(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C

Modify Date: 2024-01-13 12:55:00

(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C structure	Common Name	(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C
	CAS Number	478506-34-2	Molecular Weight	181.14900
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₆H₁₂O₆	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C

(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C is the 13C labeled (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one. (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one is an endogenous metabolite[1].

Name	l-[4-13c]sorbose
Synonym	More Synonyms

Description	(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C is the 13C labeled (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one. (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one is an endogenous metabolite[1].
Related Catalog	Research Areas >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

Molecular Formula	C₆H₁₂O₆
Molecular Weight	181.14900
Exact Mass	181.06700
PSA	110.38000

L-Sorbose-4-13C